Search research articles
Contact Us
Filters
Showing results (111-120 of 187) with videos related to
Page
of 19
Sort By:
The Journal of Urology
|
September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model
Vidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Scandinavian Journal of Urology
|
January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer
Marco Moschini, Vidit Sharma, Matteo Soligo, et al.
Urology
|
June 1, 2025
Characterizing the Hospital Caseload-Outcome Relationship for Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy: Analysis From the National Inpatient Sample
Grant M Henning, Ekamjit S Deol, Ranveer Vasdev, et al.
European Urology Oncology
|
December 12, 2022
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma
Timothy D Lyon, Eduard Roussel, Vidit Sharma, et al.
The Journal of Urology
|
June 24, 2022
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors
Matvey Tsivian, Daniel D Joyce, Vignesh T Packiam, et al.
Urology
|
April 16, 2026
Long-Term Outcomes of Partial Cystectomy for Urothelial Carcinoma In the Era of Bladder Preservation
Austin Martin, Chloe Shi, Gianni Morales Martinez, et al.
The Journal of Urology
|
May 18, 2026
<b>Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST</b>, <b>POTOMAC, and ALBAN</b>
Daniel D Joyce, Vidit Sharma, Grace E Ratcliff, et al.
Cancer
|
October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data
Daniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
Kidney Medicine
|
January 14, 2025
Glomerular and Nephron Size and Kidney Disease Outcomes: A Comparison of Manual Versus Deep Learning Methods in Kidney Pathology
Jaidip M Jagtap, Andrew R Janowczyk, Yijiang Chen, et al.
The Journal of Urology
|
March 20, 2020
Cost-Effectiveness of Maintenance bacillus Calmette-Guérin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer
Vidit Sharma, Kevin M Wymer, Bijan J Borah, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 187) with videos related to
Sort By:
Page
of 19
The Journal of Urology
|
September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model
Vidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Scandinavian Journal of Urology
|
January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer
Marco Moschini, Vidit Sharma, Matteo Soligo, et al.
Urology
|
June 1, 2025
Characterizing the Hospital Caseload-Outcome Relationship for Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy: Analysis From the National Inpatient Sample
Grant M Henning, Ekamjit S Deol, Ranveer Vasdev, et al.
European Urology Oncology
|
December 12, 2022
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma
Timothy D Lyon, Eduard Roussel, Vidit Sharma, et al.
The Journal of Urology
|
June 24, 2022
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors
Matvey Tsivian, Daniel D Joyce, Vignesh T Packiam, et al.
Urology
|
April 16, 2026
Long-Term Outcomes of Partial Cystectomy for Urothelial Carcinoma In the Era of Bladder Preservation
Austin Martin, Chloe Shi, Gianni Morales Martinez, et al.
The Journal of Urology
|
May 18, 2026
<b>Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST</b>, <b>POTOMAC, and ALBAN</b>
Daniel D Joyce, Vidit Sharma, Grace E Ratcliff, et al.
Cancer
|
October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data
Daniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
Kidney Medicine
|
January 14, 2025
Glomerular and Nephron Size and Kidney Disease Outcomes: A Comparison of Manual Versus Deep Learning Methods in Kidney Pathology
Jaidip M Jagtap, Andrew R Janowczyk, Yijiang Chen, et al.
The Journal of Urology
|
March 20, 2020
Cost-Effectiveness of Maintenance bacillus Calmette-Guérin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer
Vidit Sharma, Kevin M Wymer, Bijan J Borah, et al.
Page
of 19